The techniques for evaluating lesions suspicious for melanoma are primarily subjective visual assessments. DermTech’s Nevome offers the first non-invasive biopsy platform for aiding the detection of melanoma by analyzing gene expression and known melanoma gene mutations.
2018 AAD Abstract
- No. 6,720,145 – “Method of detection of biological factors in epidermis”
- No. 6,949,338 – “Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids”
- No. 7,183,057 – “Tape stripping methods for analysis of skin disease and pathological skin state”
- No. 7,297,480 – “Method for detection of melanoma”
- Patent Pending No. 62562250. 2017. “Non-invasive skin-based detection methods”